- Report
- March 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- March 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- March 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- December 2024
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- March 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2024
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Training
- July 2026
- 3 Hours
Global
€419EUR$493USD£350GBP
€479EUR$563USD£400GBP
- Report
- October 2025
- 82 Pages
Vietnam
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 82 Pages
Qatar
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 99 Pages
Philippines
From €4270EUR$4,850USD£3,690GBP
- Report
- October 2025
- 90 Pages
Saudi Arabia
From €4270EUR$4,850USD£3,690GBP
- Report
- June 2025
- 77 Pages
Japan
From €2157EUR$2,450USD£1,864GBP
- Report
- April 2025
- 59 Pages
Global
From €2597EUR$2,950USD£2,245GBP
- Report
- November 2024
- 82 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- October 2024
- 83 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2024
- 89 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- August 2024
- 116 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- January 2024
- 130 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- July 2023
- 100 Pages
Global
From €4270EUR$4,850USD£3,690GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more